These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 19647630)

  • 21. Improving dose homogeneity in large breasts by IMRT: efficacy and dosimetric accuracy of different techniques.
    Abo-Madyan Y; Polednik M; Rahn A; Schneider F; Dobler B; Wenz F; Lohr F
    Strahlenther Onkol; 2008 Feb; 184(2):86-92. PubMed ID: 18259700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot study of sole conformal peroperative interstitial brachyradiotherapy of early stage breast carcinoma using high-dose rate afterloading.
    Slampa P; Soumarova R; Ruzickova J; Chrenko V; Fait V; Bartlova R; Ticha H; Zaloudik J
    Neoplasma; 2005; 52(4):292-6. PubMed ID: 16059644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer.
    Major T; Niehoff P; Kovács G; Fodor J; Polgár C
    Radiother Oncol; 2006 Jun; 79(3):321-8. PubMed ID: 16730085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of radiation-induced normal tissue complications in radiotherapy using functional image data.
    Nioutsikou E; Partridge M; Bedford JL; Webb S
    Phys Med Biol; 2005 Mar; 50(6):1035-46. PubMed ID: 15798307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dosimetric comparison of IORT techniques in limited-stage breast cancer.
    Nairz O; Deutschmann H; Kopp M; Wurstbauer K; Kametriser G; Fastner G; Merz F; Reitsamer R; Menzel C; Sedlmayer F
    Strahlenther Onkol; 2006 Jun; 182(6):342-8. PubMed ID: 16703290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of (125)I stereotactic brachytherapy and LINAC radiosurgery modalities based on physical dose distribution and radiobiological efficacy.
    Viola A; Major T; Julow J
    Radiat Res; 2006 Jun; 165(6):695-702. PubMed ID: 16802870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of MammoSite brachytherapy: advantages, disadvantages and clinical outcomes.
    Bensaleh S; Bezak E; Borg M
    Acta Oncol; 2009; 48(4):487-94. PubMed ID: 19031175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer.
    Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB
    Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consequences of dose heterogeneity on the biological efficiency of ¹⁰³Pd permanent breast seed implants.
    Afsharpour H; Reniers B; Landry G; Pignol JP; Keller BM; Verhaegen F; Beaulieu L
    Phys Med Biol; 2012 Feb; 57(3):809-23. PubMed ID: 22252246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup.
    Haley M; Beriwal S; Heron DE; Kim H; Falk J; Johnson R; Mogus R
    Brachytherapy; 2009; 8(1):9-13. PubMed ID: 18955020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis.
    Shah NM; Tenenholz T; Arthur D; DiPetrillo T; Bornstein B; Cardarelli G; Zheng Z; Rivard MJ; Kaufman S; Wazer DE
    Cancer; 2004 Aug; 101(4):727-34. PubMed ID: 15305402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dose verification tool for high-dose-rate interstitial brachytherapy treatment planning in accelerated partial breast irradiation.
    Marqa MF; Caudrelier JM; Betrouni N
    Brachytherapy; 2012; 11(5):359-68. PubMed ID: 22748290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case report and dosimetric analysis of an axillary recurrence after partial breast irradiation with mammosite catheter.
    Shah AP; Dickler A; Kirk MC; Chen SS; Strauss JB; Coon AB; Turian JV; Siziopikou K; Dowlat K; Griem KL
    Med Dosim; 2008; 33(3):222-5. PubMed ID: 18674687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
    Poon E; Williamson JF; Vuong T; Verhaegen F
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dosimetric comparison of MammoSite and ClearPath high-dose-rate breast brachytherapy devices.
    Dickler A; Seif N; Kirk MC; Patel MB; Bernard D; Coon A; Dowlatshahi K; Das RK; Patel RR
    Brachytherapy; 2009; 8(1):14-8. PubMed ID: 18955018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equivalent uniform dose concept evaluated by theoretical dose volume histograms for thoracic irradiation.
    Dumas JL; Lorchel F; Perrot Y; Aletti P; Noel A; Wolf D; Courvoisier P; Bosset JF
    Phys Med; 2007 Mar; 23(1):16-24. PubMed ID: 17568539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility study on the MammoSite in early-stage breast cancer: initial experience.
    Borg M; Yeoh E; Bochner M; Butters J; van Doorn T; Farshid G; Kollias J; Kotasek D; Gill G; Lim A; Olver I; Parnis F; Rush G
    Australas Radiol; 2007 Feb; 51(1):53-61. PubMed ID: 17217490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concepts for critical organ dosimetry in three-dimensional image-based breast brachytherapy.
    Berger D; Kauer-Dorner D; Seitz W; Pötter R; Kirisits C
    Brachytherapy; 2008; 7(4):320-6. PubMed ID: 18928925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equivalent uniform dose, D(90), and V(100) correlation with biochemical control after low-dose-rate prostate brachytherapy for clinically low-risk prostate cancer.
    Miles EF; Nelson JW; Alkaissi AK; Das S; Clough RW; Anscher MS; Oleson JR
    Brachytherapy; 2008; 7(2):206-11. PubMed ID: 18359669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.